AwesomeCapital
Search This Blog
Tuesday, October 4, 2022
HHS buying $290M worth of Amgen drug Nplate for radiation emergency
HHS is purchasing $290M worth of Amgen's (NASDAQ:AMGN) Nplate (romiplostim) for acute radiation sickness due to a radiological or nuclear event.
https://seekingalpha.com/news/3888692-hhs-buying-290m-worth-of-amgen-drug-nplate-for-radiation-sickness-in-nuclear-emergency
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.